BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential

NCT07416500 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

301

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Lesions of Uncertain Malignant Potential (B3 Lesions)

Interventions

DIAGNOSTIC_TEST: MS-MLPA Methylation Analysis

Sponsor

Institute of Oncology Ljubljana